Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group
19764.5k citationsJohn M. Bennett, Daniel Catovsky et al.British Journal of Haematologyprofile →
Proposals for the classification of the myelodysplastic syndromes
19823.0k citationsJohn M. Bennett, Daniel Catovsky et al.British Journal of Haematologyprofile →
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
19992.5k citationsNancy L. Harris, Elaine S. Jaffe et al.Journal of Clinical Oncologyprofile →
Proposals for the classification of the myelodysplastic syndromes
1982993 citationsJohn M. Bennett, Daniel Catovsky et al.British Journal of Haematologyprofile →
The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues
1999649 citationsNancy L. Harris, Elaine S. Jaffe et al.Annals of Oncologyprofile →
Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.
1989565 citationsJohn M. Bennett, Georges Flandrin et al.profile →
Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO)
1991514 citationsJohn M. Bennett, Daniel Catovsky et al.British Journal of Haematologyprofile →
The Morphological Classification of Acute Lymphoblastic Leukaemia: Concordance among Observers and Clinical Correlations
1981385 citationsJohn M. Bennett, Daniel Catovsky et al.British Journal of Haematologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Georges Flandrin
Since
Specialization
Citations
This map shows the geographic impact of Georges Flandrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georges Flandrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georges Flandrin more than expected).
Fields of papers citing papers by Georges Flandrin
This network shows the impact of papers produced by Georges Flandrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georges Flandrin. The network helps show where Georges Flandrin may publish in the future.
Co-authorship network of co-authors of Georges Flandrin
This figure shows the co-authorship network connecting the top 25 collaborators of Georges Flandrin.
A scholar is included among the top collaborators of Georges Flandrin based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Georges Flandrin. Georges Flandrin is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Starza, Roberta La, Maurizio Trubia, Nicoletta Testoni, et al.. (2002). Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia.. PubMed. 87(8). 789–94.41 indexed citations
3.
Flandrin, Georges. (2001). La nouvelle classification OMS des hémopathies malignesHémopathies myéloïdes. Hématologie. 7(2). 136–141.3 indexed citations
4.
Diebold, Joachim, et al.. (2000). THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF HEMATOLOGICAL MALIGNANCIES REPORT OF THE CLINICAL ADVISORY COMMITTEE MEETING. Journal of Clinical Oncology. 13. 193–207.167 indexed citations
5.
Harris, Nancy L., Elaine S. Jaffe, J Diébold, et al.. (1999). The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues. Annals of Oncology. 10(12). 1419–1432.649 indexed citations breakdown →
6.
Flandrin, Georges, et al.. (1998). Analyse morphométrique, coloration panoptique de May-Grünwald Giemsa et contrôle de qualité.Introduction des méthodes objectives dans l'observation microscopique. Hématologie. 4(3). 233–238.1 indexed citations
7.
Flandrin, Georges. (1997). Télépathologie et banque d'images en hématologie. Hématologie. 3(3). 256–259.1 indexed citations
Jl, Harousseau, et al.. (1980). [Acute myeloblastic leukaemia in the course of non-Hodgkin's lymphoma (author's transl)].. PubMed. 9(46). 3513–6.1 indexed citations
15.
Berger, Roland, Alain Bernheim, Georges Flandrin, et al.. (1979). [Translocation t(8;14) in acute lymphoblastic leukaemia, Burkitt type (author's transl)].. PubMed. 8(3). 181–3.3 indexed citations
16.
Bennett, John M., Daniel Catovsky, Georges Flandrin, et al.. (1976). Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group. British Journal of Haematology. 33(4). 451–458.4454 indexed citations breakdown →
17.
Flandrin, Georges, et al.. (1975). [Acute mast-cell leukemia. Cytochemical and ultrastructural study, about a particular case (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 15(3). 319–32.9 indexed citations
Flandrin, Georges, M Boiron, J Lasneret, et al.. (1967). [Biopsy study of lymphocytic infiltrations of the bone marrow].. PubMed. 75(49). 2497–502.5 indexed citations
20.
Marchal, G, G Duhamel, M Samama, & Georges Flandrin. (1964). [MASSIVE THROMBOSIS OF THE VESSELS OF AN EXTREMITY DURING A CONGENITAL HYPOFIBRINEMIA].. PubMed. 4. 81–9.11 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.